Pokey, I look at this PR like this and I make a comparison to the Kentucky Derby. Most companies involved with the Covid vaccines are 25-50 feet from the finish line. GNBT's jockey is just now getting his gear together and the horse isn't even in the starting lane. Therein lies the problem with the stock price. Generex just does not have credibility. Wish things were different but that is the reality of it all.
(1)
(1)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links